The Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria known as pneumococcus ...

Sanofi Pasteur manufactures the DTP antigens used in the vaccine while Merck/MSD provides the Hib and HBV antigens. FDA approval comes almost three years after Vaxelis was registered in the EU ...

Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines. This expansion of their 2016 collaboration will ...

Merck's strong entrenchment in vaccines adds a layer of competitive protection from intellectual property and cost advantages, as the company's large-scale production enables a lower cost base ...

Other studies show that rVSV-ZEBOV vaccine reduces the risk of death in Ebola patients who were vaccinated before and even after exposure. Merck & Co Inc’s MRK rVSV-ZEBOV vaccine is the only WHO ...

Merck’s (NYSE:MRK) human papillomavirus (HPV) vaccine Gardasil 9 has met key efficacy goals in a pivotal late-stage trial involving Japanese males ages 16 to 26 years. The Phase 3 V503-064 trial ...

The Global Rabies Diagnostics Market was valued at approximately USD 2.11 Billion in 2023 and is projected to grow to around USD 3.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) ...

Hesitancy around vaccines has spilled over to pet owners in recent years, sparking concern about the resurgence of rabies, a ...

According to GlobalData, the recombinant vesicular stomatitis virus – Zaire Ebola virus (rVSV-ZEBOV) vaccine is marketed by Merck under the name Ervebo. It has been available in the US and EU ...

Students of the North-West University, the SANDF and the Department of Agriculture had a Rabies Vaccination Drive on September 18. Members of the community were urged to bring their cats and dogs ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...